Sickle cell gene therapies offer new hope, but access remains a major challenge

How 1 sources are covering this

• CNBCLean R·12m ago

  Sickle cell gene therapies offer new hope, but access remains a major challenge

  FDA-approved gene therapies for sickle cell disease offer a chance to help patients, but factors including cost and access have slowed their use.

  Read at CNBC →